• TCT 2013: Interview with Clemens von Birgelen, MD

    Ron Waksman, MD, interviews Clemens von Birgelen, MD, on DUTCH PEERS (TWENTE II): A Prospective, Randomized “All-Comers” Trial of Zotarolimus-Eluting Stents Versus Everolimus-Eluting Coronary Stents.